[HTML][HTML] Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
[PDF][PDF] Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
M Schmidt, D Hajage, G Lebreton, A Monsel, G Voiriot… - 2020 - aphp.aphp.fr
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
M Schmidt, D Hajage, G Lebreton… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
M Schmidt, D Hajage, G Lebreton… - The Lancet …, 2020 - hal.sorbonne-universite.fr
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
[引用][C] Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID‐19: a retrospective cohort study. Lancet
M Schmidt - Respir Med, 2020 - cir.nii.ac.jp
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome
associated with COVID‐19: a retrospective cohort study. Lancet | CiNii Research CiNii 国立 …
associated with COVID‐19: a retrospective cohort study. Lancet | CiNii Research CiNii 国立 …
[HTML][HTML] Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
M Schmidt, D Hajage, G Lebreton… - The Lancet …, 2020 - ncbi.nlm.nih.gov
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.
M Schmidt, D Hajage, G Lebreton, A Monsel, G Voiriot… - 2020 - cabidigitallibrary.org
Background: Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
[PDF][PDF] Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
M Schmidt, D Hajage, G Lebreton, A Monsel, G Voiriot… - Lancet, 2020 - researchgate.net
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
M Schmidt, D Hajage, G Lebreton, A Monsel… - The Lancet Respiratory …, 2020 - hal.science
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.
M Schmidt, D Hajage, G Lebreton… - The Lancet …, 2020 - europepmc.org
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …